THYROID CANCER
Clinical trials for THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new THYROID CANCER trials appear
Sign up with your email to follow new studies for THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo takes on advanced cancers in early trial
Disease control CompletedThis early-phase trial tested an experimental drug called KVA12123, given alone or with the immunotherapy Keytruda, in 40 adults with advanced solid tumors (like lung, breast, or colon cancer) that had stopped responding to standard treatments. The main goals were to check safety…
Matched conditions: THYROID CANCER
Phase: PHASE1, PHASE2 • Sponsor: Kineta Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New radioactive compound shows promise in targeting Hard-to-Treat cancers
Disease control CompletedThis early-phase study tested a new radioactive drug called 177Lu-CTR-FAPI in 12 people with advanced solid tumors (breast cancer, sarcoma, or thyroid cancer) that had spread and no longer responded to standard treatments. The main goals were to see if the drug is safe and how it…
Matched conditions: THYROID CANCER
Phase: EARLY_PHASE1 • Sponsor: Lanzhou University Second Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Exergaming and mediterranean diet tested for thyroid cancer recovery
Disease control CompletedThis study looked at whether playing active video games (exergaming) and following a Mediterranean diet could help people who had their thyroid removed due to cancer. 80 adults were split into four groups: one did exergaming, one followed the diet, one did both, and one had no ex…
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: Nabil Mahmoud Ismail Abdel-Aal • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control CompletedThis early-phase study tested a combination of two experimental drugs (BGB-283 and PD-0325901) in 91 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and see if the drugs could shrink tumors. The trial is no…
Matched conditions: THYROID CANCER
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Which dose of vandetanib works best for thyroid cancer?
Disease control CompletedThis study tested two daily doses (150mg vs 300mg) of the drug vandetanib in 81 adults with advanced medullary thyroid cancer that had spread or caused symptoms. The goal was to see which dose better shrinks tumors and how side effects compare. Patients took the drug for up to 24…
Matched conditions: THYROID CANCER
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New pill shows promise in slowing rare thyroid cancer
Disease control CompletedThis phase 3 trial tested a daily oral drug called vandetanib (ZD6474) against a placebo in 331 people with advanced medullary thyroid cancer that could not be removed by surgery. The main goal was to see if the drug could delay tumor growth. Researchers also measured how many pa…
Matched conditions: THYROID CANCER
Phase: PHASE3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can two drugs reboot radioiodine therapy for tough thyroid cancers?
Disease control CompletedThis early-phase trial tested two drugs, vemurafenib and copanlisib, in 8 people with advanced BRAF-mutant thyroid cancers that had stopped responding to radioiodine therapy. The goal was to see if the combination could make tumors sensitive to radioiodine again and to find the s…
Matched conditions: THYROID CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 14:34 UTC
-
AI outperforms some doctors in spotting thyroid cancer on ultrasound
Diagnosis CompletedThis study tested an artificial intelligence (AI) system called Vision-LSTM to see if it could accurately diagnose a specific type of thyroid nodule (TI-RADS 4b) from ultrasound images. Researchers used images from 401 patients and compared the AI's performance to that of junior …
Matched conditions: THYROID CANCER
Sponsor: Ma Zhe • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Simple muscle relaxation technique shows promise for thyroid cancer pain
Symptom relief CompletedThis study tested whether a simple relaxation exercise, called progressive muscle relaxation (PMR), could help reduce pain and improve quality of life in people with thyroid cancer. Thirty-two patients undergoing chemotherapy were randomly assigned to do either PMR plus gentle st…
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Tiny scope, big difference? study tests Microscope-Assisted thyroid surgery
Symptom relief CompletedThis study compared two types of thyroid surgery: one using a microscope and the standard approach. Researchers looked at blood loss, nerve damage, and low calcium levels after surgery in 74 patients with thyroid cancer or other thyroid conditions. The goal was to see if the micr…
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: Shahida Islam Medical Complex • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New nerve block combo could cut opioid use after thyroid surgery
Symptom relief CompletedThis study tested whether adding dexmedetomidine to a standard nerve block (superficial cervical plexus block) improves pain control after thyroid surgery. Fifty-eight adults undergoing thyroid surgery were randomly assigned to receive the nerve block with or without dexmedetomid…
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: Udayana University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New surgical tool shows promise in thyroid cancer operations
Symptom relief CompletedThis study tested a new ultrasonic surgical system designed to cut and seal tissue during thyroid cancer surgery. Researchers compared its performance and safety to standard methods in 136 patients. The goal was to see if the new tool works just as well for helping surgeons remov…
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: Ezisurg Medical Co. Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Can a gel and a mesh stop Post-Surgery neck adhesions?
Symptom relief CompletedThis study tested whether applying oxidized regenerated cellulose and hyaluronic acid during thyroid surgery can prevent painful adhesions that often form after the procedure. 45 adults with benign goiter or thyroid cancer were enrolled. The goal was to see if these barriers redu…
Matched conditions: THYROID CANCER
Phase: PHASE1 • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 19:16 UTC
-
Virtual reality goggles calm nerves before thyroid surgery
Symptom relief CompletedThis study tested whether using a virtual reality headset with relaxing hypnosis techniques could lower stress in people about to have their thyroid removed. Eighty-two adults used the headset for 30 minutes before and after surgery. Researchers measured anxiety levels to see if …
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Jun 26, 2026 17:28 UTC
-
Thyroid cancer Drug's side effect on body mass measured in small study
Knowledge-focused CompletedThis completed study from the University of Pisa looked at how the thyroid cancer drug selpercatinib affects body composition. Fifteen adults on the drug had their lean mass and energy expenditure measured. The goal was simply to observe and gather data, not to test a new treatme…
Matched conditions: THYROID CANCER
Sponsor: University of Pisa • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New tool aims to curb overtreatment in Low-Risk thyroid cancer
Knowledge-focused CompletedThis pilot study tested a tool called CQUPLE, designed to help patients with low-risk thyroid cancer understand their treatment options and avoid overtreatment. Fifty patients were split into two groups: one received the CQUPLE decision aid and question list, while the other got …
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Can a smartphone app ease the burden for young cancer survivors?
Knowledge-focused CompletedThis completed trial tested an interactive survivorship program for adolescent and young adult cancer survivors. The program included a mobile app, telehealth support, and printed materials to help survivors access healthcare resources, improve self-management skills, and reduce …
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Head tilt during thyroid surgery may squeeze the optic nerve
Knowledge-focused CompletedThis study looked at how changing the head position during thyroid surgery affects the optic nerve sheath diameter, which can indicate pressure inside the skull. Researchers measured this with ultrasound in 49 patients before and after positioning. They also tracked headache seve…
Matched conditions: THYROID CANCER
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Can a simple conversation tool reduce unnecessary thyroid biopsies?
Knowledge-focused CompletedThis study tested a digital conversation aid to help patients and doctors make shared decisions about thyroid biopsy. Researchers enrolled 107 adults with thyroid nodules to see if using the tool during clinic visits was practical. The goal was to gather information for planning …
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
New scan could Fine-Tune radiation for thyroid cancer patients
Knowledge-focused CompletedThis study tested a special radioactive substance called 124-Iodine to see how much radiation each thyroid cancer spot in the body receives. The goal was to help doctors decide the right dose of standard treatment (131-Iodine) and avoid giving unnecessary radiation to patients wh…
Matched conditions: THYROID CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Hidden cancer cells in lymph nodes may force second thyroid surgery in many patients
Knowledge-focused CompletedThis study looked at 314 patients with small, early-stage papillary thyroid cancer who had surgery to remove half of the thyroid. During the operation, doctors checked nearby lymph nodes for hidden cancer spread. If cancer was found, the rest of the thyroid was removed in the sam…
Matched conditions: THYROID CANCER
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:45 UTC